ArticleMaternal & child nutrition2025
Profits Before Health? New Zealand Government Rejection of Stricter Infant Formula Marketing Standards and the Lobbying Behind It.
Article in Maternal & child nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2024, the New Zealand (NZ) government made a rare departure from the joint food standards programme with Australia, administered by Food Standards Australia New Zealand (FSANZ). This paper presents a timely case study of how transnational dairy and baby food corporations lobbied the NZ government to reject updated infant formula standards, despite strong evidence and support across Australia for reform. Globally, transnational corporations dominate commercial milk formula industry, and industry and utilise lobbying strategies to delay and limit regulation. Drawing on original data from official information act requests, we examine the political dynamics surrounding infant formula regulation and the implications for breastfeeding protection and health governance in the region. Despite FSANZ's evidence-based decisions to improve labelling, restrict health claims, and enhance consumer protection, NZ bowed to the lobbying pressure of key companies who had cited risks to exports, jobs and future product development. Lobbying by these companies targeted the Prime Minister and key ministers, demonstrating a remarkable level of access and influence. This case exposes the weaknesses in NZ's political transparency laws, where no mandatory lobbying registers and reporting requirements exist. We conclude that it is crucial for governments to make policy decisions without the influence of the baby food industry and provide a strong argument for better regulation of corporate lobbying. Infant and young child health must be prioritised over profit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.